-+ 0.00%
-+ 0.00%
-+ 0.00%

Takeda Reports 52-Week Phase 3 Data Showing Rusfertide Maintains Hematocrit Control in Polycythemia Vera

路透·12/06/2025 14:30:31

登录查看新闻详情